941 related articles for article (PubMed ID: 11916247)
21. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
22. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
23. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
[TBL] [Abstract][Full Text] [Related]
24. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
25. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
[TBL] [Abstract][Full Text] [Related]
26. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
[TBL] [Abstract][Full Text] [Related]
27. HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells.
Ammerpohl O; Thormeyer D; Khan Z; Appelskog IB; Gojkovic Z; Almqvist PM; Ekström TJ
Biochem Biophys Res Commun; 2004 Nov; 324(1):8-14. PubMed ID: 15464975
[TBL] [Abstract][Full Text] [Related]
28. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis.
Agard C; Ligeza C; Dupas B; Izembart A; El Kouri C; Moullier P; Ferry N
Cancer Gene Ther; 2001 Feb; 8(2):128-36. PubMed ID: 11263528
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
30. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells.
Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS
Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216
[TBL] [Abstract][Full Text] [Related]
32. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system.
Bai S; Du L; Liu W; Whittle IR; He L
Biochem Biophys Res Commun; 1999 Jun; 259(2):455-9. PubMed ID: 10362529
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ATP-sensitive potassium channels increases HSV-tk/GCV bystander effect in U373 human glioma cells by enhancing gap junctional intercellular communication.
Paíno T; Gangoso E; Medina JM; Tabernero A
Neuropharmacology; 2010 Nov; 59(6):480-91. PubMed ID: 20603136
[TBL] [Abstract][Full Text] [Related]
34. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
[TBL] [Abstract][Full Text] [Related]
35. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
[TBL] [Abstract][Full Text] [Related]
36. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions.
Vrionis FD; Wu JK; Qi P; Waltzman M; Cherington V; Spray DC
Gene Ther; 1997 Jun; 4(6):577-85. PubMed ID: 9231074
[TBL] [Abstract][Full Text] [Related]
37. An experimental application of gene therapy for human retinoblastoma.
Hayashi N; Ido E; Ohtsuki Y; Ueno H
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):265-72. PubMed ID: 9950583
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
39. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
40. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
